By Caroline Chen Sep 16, 2014 8:21 AM CT Testosterone supplements used last year by about 2.3 million men are spurring debates over how necessary and safe they may be, even as U.S. regulators consider approving a new product. Food and Drug Administration advisers tomorrow will consider whether the drugs are being prescribed to the […]Read More
Article by: JOE CARLSON, Star Tribune Updated: September 10, 2014 – 1:19 AM A jury hit Boston Scientific with $73.5 million in damages this week in one of thousands of suits the device maker faces over an implant intended to treat incontinence. The verdict in a Dallas court is part of a tsunami of product-defect […]Read More
Johnson & Johnson faces a new product liability lawsuit that alleges side effects of Levaquin caused peripheral neuropathy for a Maryland woman, leaving her with the severe and often permanent form of nerve damage after using the popular antibiotic. The complaint (PDF) was filed last month by Karyn Grossman in the U.S. District Court for […]Read More
The personal injury lawyers at Taylor Martino Rowan are reviewing potential lawsuits against the makers of talcum powder products. A study published in Cancer Prevention Research suggests that the use of talcum powder in the genital area by women leads to a higher risk of developing ovarian cancer. The data on 2,000 women showed that […]Read More
The New Jersey Superior Court judge overseeing thousands of transvaginal mesh lawsuits filed against Ethicon Inc. has upheld the $11.1 million verdict awarded last year to the plaintiff in the proceeding’s first bellwether trial. Judge Carol Higbee of Atlantic County Superior Court denied Ethicon’s motions for a new trial and judgment notwithstanding the verdict on […]Read More
By Shirley S. Wang Surgical mesh kits used to repair a condition called pelvic organ prolapse should be more closely regulated, the Food and Drug Administration announced on Tuesday, signaling heightened recognition of the safety issues associated with the devices currently on the market. The FDA’s proposed changes, if finalized, would reclassify the medical devices […]Read More
Consumer Inquiries: 888-INFO-FDA, DICE@fda.hhs.gov FDA issues proposals to address risks associated with surgical mesh for transvaginal repair of pelvic organ prolapse The U.S. Food and Drug Administration today issued two proposed orders to address the health risks associated with surgical mesh used for transvaginal repair of pelvic organ prolapse (POP). If finalized, the orders would reclassify […]Read More
Our Attorney, Mallory Mangold, is sponsoring the Hammerin’ For Habitat 5K Fun Run/Walk on Saturday, February 22, 2014. Mallory says, “I am learning more and more about Habitat. They don’t just give away homes to needy families. The families have to go through a rigorous screening process to qualify. If the family qualifies, they are given […]Read More
From BLOOMBERG NEWS By Andrew Harris Feb 5, 2014 2:34 PM CT Abbott Laboratories (ABT) and AbbVie Inc., the company it spun off last year, hid the dangers of using the testosterone replacement drug AndroGel, five men claimed in lawsuits. Their complaints, filed in the federal court in Chicago yesterday, came four days after the […]Read More
February 6, 2014 | By Mark Hollmer Johnson & Johnson’s Ethicon arm lost an early fight ahead of trials alleging that it sold faulty vaginal mesh implants that harmed women. Patients’ attorneys had accused the company of inappropriately destroying or losing hundreds of thousands of product documents relating to the issue, and a judge has […]Read More
